Heimdall Insights

Global Urticaria Drugs Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: August 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Urticaria Drugs Market was valued at $4.8 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 14.5% CAGR, to an estimated market size of $9.4 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global urticaria drugs market encompasses pharmaceutical treatments for acute and chronic urticaria (hives), including antihistamines, monoclonal antibodies, and anti-inflammatory medications. The scope includes both prescription and over-the-counter (OTC) drugs used to manage symptoms like wheals and angioedema, while excluding non-pharmacological skin treatments.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Urticaria Drugs Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

Segments

  • Monoclonal Antibodies (Biologics)
  • Antihistamines
  • Other Medications